Home/Filings/4/0001415889-24-006977
4//SEC Filing

Lloyd Brian G. 4

Accession 0001415889-24-006977

CIK 0000856982other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 12:47 PM ET

Size

17.6 KB

Accession

0001415889-24-006977

Insider Transaction Report

Form 4
Period: 2024-03-04
Lloyd Brian G.
CHIEF LEGAL OFFICER, SECRETARY
Transactions
  • Award

    Common Stock, No Par Value

    2024-03-04+7,31923,239 total
  • Award

    Common Stock, No Par Value

    2024-03-04+7,11030,349 total
  • Tax Payment

    Common Stock, No Par Value

    2024-03-04$76.51/sh4,567$349,42125,782 total
Holdings
  • Non-qualified stock options (right to buy)

    Exercise: $56.25From: 2022-03-19Exp: 2028-03-19Common Stock (9,681 underlying)
    9,681
  • Non-qualified stock options (right to buy)

    Exercise: $44.80From: 2019-03-02Exp: 2025-03-02Common Stock (25,000 underlying)
    25,000
  • Non-qualified stock options (right to buy)

    Exercise: $65.03From: 2023-02-28Exp: 2029-02-28Common Stock (8,094 underlying)
    8,094
  • Non-qualified stock options (right to buy)

    Exercise: $37.71From: 2021-02-26Exp: 2027-02-26Common Stock (16,722 underlying)
    16,722
  • Non-qualified stock options (right to buy)

    Exercise: $55.73From: 2020-03-01Exp: 2026-03-01Common Stock (30,000 underlying)
    30,000
  • Non-qualified stock options (right to buy)

    Exercise: $70.58From: 2024-02-28Exp: 2030-02-28Common Stock (13,576 underlying)
    13,576
Footnotes (9)
  • [F1]Represents a grant of restricted stock units ("RSUs"). The RSUs vest in four equal annual installments on each of the first four anniversaries of the grant date, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
  • [F2]These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 03.19.2021.
  • [F3]Reflects shares of Common Stock surrendered by the Reporting Person to satisfy tax withholding obligations in connection with the issuance of the performance stock units. These shares were not sold in an open-market transaction.
  • [F4]Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
  • [F5]Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
  • [F6]Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.
  • [F7]Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
  • [F8]Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.
  • [F9]Becomes exercisable in equal annual installments of 25% commencing on 02/28/2024.

Issuer

MERIT MEDICAL SYSTEMS INC

CIK 0000856982

Entity typeother

Related Parties

1
  • filerCIK 0001671772

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 12:47 PM ET
Size
17.6 KB